JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leeder, J. S.
Right arrow Articles by Spielberg, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leeder, J. S.
Right arrow Articles by Spielberg, S. P.

Human anti-cytochrome P450 antibodies in aromatic anticonvulsant- induced hypersensitivity reactions

JS Leeder, RJ Riley, VA Cook and SP Spielberg

Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

Aromatic anticonvulsants such as phenytoin, phenobarbital and carbamazepine are associated with a hypersensitivity syndrome (fever, rash lymphadenopathy, hepatitis) suggestive of an immune component. We have identified immunoglobulin G antibodies in the sera of nine affected patients which recognize a 53-kD protein which is constitutively expressed and PB inducible in rat liver microsomes. No such reactivity was observed in sera from healthy controls, patients on chronic phenytoin therapy without toxicity or patients with hepatic failure not receiving anticonvulsants. Using highly purified rat hepatic cytochrome P450, P450 3A1 was identified as the major antigenic species, whereas less intense reactivity was noted with P450 2C11. P450 2C6 and 3A2 were minor antigens in some patients. In all patients, the apparent constitutive and phenobarbital-inducible expression of the antigen was a composite effect of antibodies reacting with at least two isozymes, one of which was constitutively expressed and the other PB inducible. In human liver, a 53-kD antigen was expressed to a greater extent in microsomes from a patient with a fatal hepatotoxic reaction to phenytoin compared to microsomes from normal liver or from a sulfonamide hepatitis patient. Western blotting with microsomes prepared from lymphoblastoid cell lines transfected with different human hepatic cytochromes P450 failed to identify P450s 1A1, 1A2, 2A3, 2B6, 2C9, 2D6, 2E1, 3A4 or epoxide hydrolase as the target antigen. Identification of the antigen will be important in understanding the relationship between drug metabolism and the subsequent immune response in the pathogenesis of these rare but severe forms of drug toxicity.

Volume 263, Issue 1, pp. 360-367, 10/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Vidali, M. Hidestrand, E. Eliasson, E. Mottaran, E. Reale, R. Rolla, G. Occhino, E. Albano, and M. Ingelman-Sundberg
Use of Molecular Simulation for Mapping Conformational CYP2E1 Epitopes
J. Biol. Chem., December 3, 2004; 279(49): 50949 - 50955.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Nakajima, N. Sakata, N. Ohashi, T. Kume, and T. Yokoi
Involvement of Multiple UDP-glucuronosyltransferase 1A Isoforms in Glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in Human Liver Microsomes
Drug Metab. Dispos., November 1, 2002; 30(11): 1250 - 1256.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Pirmohamed, K. Lin, D. Chadwick, and B. K. Park
TNF{{alpha}} promoter region gene polymorphisms in carbamazepine-hypersensitive patients
Neurology, April 10, 2001; 56(7): 890 - 896.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H. Yamazaki, T. Komatsu, K. Takemoto, M. Saeki, Y. Minami, Y. Kawaguchi, N. Shimada, M. Nakajima, and T. Yokoi
Decreases in Phenytoin Hydroxylation Activities Catalyzed by Liver Microsomal Cytochrome P450 Enzymes in Phenytoin-Treated Rats
Drug Metab. Dispos., April 1, 2001; 29(4): 427 - 434.
[Abstract] [Full Text]


Home page
Arch DermatolHome page
J. R. Sullivan and N. H. Shear
The Drug Hypersensitivity Syndrome: What Is the Pathogenesis?
Arch Dermatol, March 1, 2001; 137(3): 357 - 364.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. De Berardinis, C. Moulis, M. Maurice, P. Beaune, D. Pessayre, D. Pompon, and J. Loeper
Human Microsomal Epoxide Hydrolase Is the Target of Germander-Induced Autoantibodies on the Surface of Human Hepatocytes
Mol. Pharmacol., September 1, 2000; 58(3): 542 - 551.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
J. Loeper, B. Louérat-Oriou, C. Duport, and D. Pompon
Yeast Expressed Cytochrome P450 2D6 (CYP2D6) Exposed on the External Face of Plasma Membrane Is Functionally Competent
Mol. Pharmacol., July 1, 1998; 54(1): 8 - 13.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. E. Cribb, L. R. Pohl, S. P. Spielberg, and J. S. Leeder
Patients with Delayed-Onset Sulfonamide Hypersensitivity Reactions Have Antibodies Recognizing Endoplasmic Reticulum Luminal Proteins
J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 1064 - 1072.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
M. G. Sturgill and G. H. Lambert
Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function
Clin. Chem., August 1, 1997; 43(8): 1512 - 1526.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics.